Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetics Modifications and Subclinical Atherosclerosis in Obstructive Sleep Apnea: The EPIOSA Study

NCT02131610 is registered in ClinicalTrials.gov with Aragon Institute of Health Sciences as lead sponsor.

NCT NCT02131610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02131610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetics Modifications and Subclinical Atherosclerosis in Obstructive Sleep Apnea: The EPIOSA Study
Lead sponsor
Aragon Institute of Health Sciences
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
March 31, 2019
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep apnea, snoring